Entry |
|
Name |
FAH deficiency in tyrosine degradation
|
Definition |
Tyr -- TAT >> HPD >> HGD >> GSTZ1 >> FAH* |
Expanded |
C00082 -- 6898 >> 3242 >> 3081 >> 2954 >> 2184v1 |
Class |
nt06016 Phenylalanine and tyrosine metabolism
|
Type |
Variant
|
Disease |
|
Gene |
6898 | TAT; tyrosine aminotransferase |
3242 | HPD; 4-hydroxyphenylpyruvate dioxygenase |
3081 | HGD; homogentisate 1,2-dioxygenase |
2954 | GSTZ1; glutathione S-transferase zeta 1 |
2184 | FAH; fumarylacetoacetate hydrolase |
|
Variant |
|
Metabolite |
|
Reference |
|
Authors |
Arranz JA, Pinol F, Kozak L, Perez-Cerda C, Cormand B, Ugarte M, Riudor E |
Title |
Splicing mutations, mainly IVS6-1(G>T), account for 70% of fumarylacetoacetate hydrolase (FAH) gene alterations, including 7 novel mutations, in a survey of 29 tyrosinemia type I patients. |
Journal |
|
LinkDB |
|